FDA Approves Prolia, New Treatment for Osteopososis

FDA OKs Prolia for High-Risk Osteoporosis Twice-Yearly Injection Is First 'Biologic' Bone-Loss Treatment WebMD Medical News By Daniel J. DeNoon Reviewed by Laura J. Martin, MD More from WebMD Nitroglycerin...

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
Mobile advertising for this site is available on Local Ad Buy.